Literature DB >> 21598960

Long-range effects of a peripheral mutation on the enzymatic activity of cytochrome P450 1A2.

Tao Zhang1, Limin Angela Liu, David F V Lewis, Dong-Qing Wei.   

Abstract

The human cytochrome P450 1A2 is an important drug metabolizing and procarcinogen activating enzyme. An experimental study found that a peripheral mutation, F186L, at ∼26 Å away from the enzyme's active site, caused a significant reduction in the enzymatic activity of 1A2 deethylation reactions. In this paper, we explored the effects of this mutation by carrying out molecular dynamics simulations and structural analyses. We found that the long-range effects of the F186L mutation were through a change in protein flexibility and a collective protein motion that caused the main substrate access channel to be mostly closed in the mutant. Our work is the first that combined both access channel analysis and protein motion analysis to elucidate mechanisms of mutation-induced allostery in a CYP protein. Such structural modeling and analysis approaches may be applied to other CYP proteins and other enzymes with buried active sites and may help guide protein engineering and drug design.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21598960     DOI: 10.1021/ci200112b

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

Review 1.  Substrate tunnels in enzymes: structure-function relationships and computational methodology.

Authors:  Laura J Kingsley; Markus A Lill
Journal:  Proteins       Date:  2015-02-28

Review 2.  Bioinformatics and variability in drug response: a protein structural perspective.

Authors:  Jennifer L Lahti; Grace W Tang; Emidio Capriotti; Tianyun Liu; Russ B Altman
Journal:  J R Soc Interface       Date:  2012-05-02       Impact factor: 4.118

3.  Distal effect of amino acid substitutions in CYP2C9 polymorphic variants causes differences in interatomic interactions against (S)-warfarin.

Authors:  Panida Lertkiatmongkol; Anunchai Assawamakin; George White; Gaurav Chopra; Pornpimol Rongnoparut; Ram Samudrala; Sissades Tongsima
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

4.  In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β-dihydroexemestane.

Authors:  Amity Peterson; Zuping Xia; Gang Chen; Philip Lazarus
Journal:  Pharmacol Res Perspect       Date:  2017-04-27

Review 5.  Ligand Access Channels in Cytochrome P450 Enzymes: A Review.

Authors:  Philippe Urban; Thomas Lautier; Denis Pompon; Gilles Truan
Journal:  Int J Mol Sci       Date:  2018-05-30       Impact factor: 5.923

6.  In silico screening and analysis of nonsynonymous SNPs in human CYP1A2 to assess possible associations with pathogenicity and cancer susceptibility.

Authors:  Leila Navapour; Navid Mogharrab
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

7.  One Plus One Makes Three: Triangular Coupling of Correlated Amino Acid Mutations.

Authors:  Martin Werner; Vytautas Gapsys; Bert L de Groot
Journal:  J Phys Chem Lett       Date:  2021-03-24       Impact factor: 6.475

8.  Molecular dynamics of CYP2D6 polymorphisms in the absence and presence of a mechanism-based inactivator reveals changes in local flexibility and dominant substrate access channels.

Authors:  Parker W de Waal; Kyle F Sunden; Laura Lowe Furge
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

Review 9.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.